Daily Ards Research Analysis
Today’s papers address critical care delivery at non-tertiary sites and neonatal respiratory complications. A 10-year retrospective analysis suggests venovenous ECMO can be performed safely in peripheral hospitals with specialist support, achieving 48% ICU survival. A neonatal case report highlights iatrogenic pneumothorax risk during early respiratory support, underscoring cautious oxygen/flow strategies and vigilant monitoring.
Summary
Today’s papers address critical care delivery at non-tertiary sites and neonatal respiratory complications. A 10-year retrospective analysis suggests venovenous ECMO can be performed safely in peripheral hospitals with specialist support, achieving 48% ICU survival. A neonatal case report highlights iatrogenic pneumothorax risk during early respiratory support, underscoring cautious oxygen/flow strategies and vigilant monitoring.
Research Themes
- Decentralized ECMO implementation and outcomes
- Time-to-ECMO initiation and systems of care
- Neonatal respiratory support safety and iatrogenic complications
Selected Articles
1. [ECMO therapies in a low-volume, peripheral hospital].
In a 10-year, single-center retrospective analysis at a peripheral regional hospital, 54 ECMO cases (53 VV, 1 VA) were initiated, with 48% ICU survival among non-transferred patients. The study suggests decentralized ECMO can be safe and effective when supported by a collaborating specialized center, potentially reducing delays to cannulation.
Impact: This study provides real-world outcome data indicating that peripheral hospitals can safely implement ECMO with specialist support, informing system design for time-sensitive respiratory failure care.
Clinical Implications: Supports hub-and-spoke ECMO models, on-site cannulation to minimize delays, structured collaboration/tele-ECMO, and standardized training/protocols at peripheral hospitals.
Key Findings
- Over 2013–2023, 54 ECMO runs were performed (53 venovenous, 1 venoarterial) at a peripheral hospital.
- Four patients were transferred after ECMO initiation; among the remaining 50, 24 survived ICU care (48% survival).
- Findings suggest safe, effective ECMO delivery in peripheral hospitals when supported by a specialized center, limiting transfers to complicated courses.
Methodological Strengths
- Consecutive, 10-year single-center dataset capturing all ECMO cases
- Clear reporting of modality (VV/VA), transfers, and ICU survival
Limitations
- Retrospective, single-center design with small sample size
- No risk adjustment or comparator group to benchmark outcomes
Future Directions: Develop multicenter registries to benchmark decentralized ECMO, evaluate time-to-ECMO metrics, and test standardized training/tele-ECMO protocols in prospective designs.
INTRODUCTION: Extracorporeal membrane oxygenation (ECMO) is a therapeutic option for otherwise refractory pulmonary or cardiac failure. While ECMO therapy, as a highly invasive and high-risk procedure, is primarily offered at specialized centers, the time between the indication for and the implementation of ECMO therapy is outcome-relevant. This raises the question of whether ECMO therapy can be safely and successfully implemented in peripheral hospitals. METHODS: This retrospective analysis comprised all ECMO patients of a regional hospital for the period 2013-2023. Demographic data as well as therapy and survival data were recorded. RESULTS: During the 10-year observation period, 54 ECMO treatments were performed at the center (53 venovenous ECMO, 1 venoarterial ECMO), of which four were transferred to a specialized center after the therapy was initiated. Of the remaining 50 patients, 24 survived the intensive care therapy (48%). CONCLUSION: The present study demonstrates that ECMO therapies can be performed safely and with similar outcomes at peripheral hospitals, particularly if supported by a collaborating specialized center. Thus, transfers to specialized centers can be limited to patients with complicated courses. ZUSAMMENFASSUNG: HINTERGRUND: Extrakorporale Membranoxygenierung (ECMO) ist eine Therapieoption für anderweitig therapierefraktäre pulmonale bzw. kardiale Insuffizienz. Während die ECMO-Therapie als hochinvasives und risikoreiches Verfahren vornehmlich an spezialisierten Zentren vorgehalten wird, andererseits jedoch die Zeit zwischen Indikationsstellung und Initiierung der ECMO-Therapie relevant für das Behandlungsergebnis ist, stellt sich die Frage, ob auch in peripheren Krankenhäusern eine ECMO-Therapie sicher und erfolgreich eingesetzt werden kann. METHODIK: Retrospektiv wurden an einem peripheren regionalversorgenden Krankenhaus über einen Zeitraum von 2013 bis 2023 alle Patienten erfasst, die eine ECMO-Therapie erhielten. Es wurden demografische Daten sowie Therapie- und Überlebensdaten erfasst. ERGEBNISSE: Im 10-jährigen Beobachtungszeitraum fanden an dem Zentrum 54 ECMO-Behandlungen statt (53 venovenöse ECMO, 1 venoarterielle ECMO), von denen 4 im weiteren Verlauf nach Therapieinitiierung an ein Zentrum verlegt wurden. Von den verbleibenden 50 Patienten überlebten 24 die intensivstationäre Therapie (48 %). SCHLUSSFOLGERUNG: Die vorliegende Untersuchung zeigt, dass auch an peripheren Krankenhäusern ECMO-Therapien sicher und mit gleichem Erfolg durchgeführt werden können, insbesondere wenn eine Anbindung an ein spezialisiertes Zentrum gewährleistet ist. So können Verlegungen an Zentren auf Patienten mit komplikativem Verlauf reduziert werden.
2. Iatrogenic pneumothorax in a term neonate.
A term neonate developed respiratory distress shortly after birth and later was identified to have iatrogenic pneumothorax during early oxygen therapy via nasal cannula. The report emphasizes the need for cautious respiratory support settings and close monitoring to prevent barotrauma.
Impact: Educational value in recognizing iatrogenic pneumothorax risk during routine neonatal respiratory support and reinforcing safe oxygen/flow titration.
Clinical Implications: Encourages careful titration of oxygen and flow in neonates, early recognition of pneumothorax signs (cyanosis, distress, grunting), and readiness for prompt intervention pathways.
Key Findings
- Term neonate with normal birth parameters developed early respiratory distress with cyanosis and grunting.
- Iatrogenic pneumothorax occurred during early oxygen therapy via nasal cannula (6 L, 25% FiO2).
- Highlights need for cautious respiratory support settings and vigilant monitoring to avoid barotrauma.
Methodological Strengths
- Clear presentation of early clinical signs and initial oxygen therapy parameters
- Practical, bedside-focused learning points for neonatal teams
Limitations
- Single case with limited generalizability
- Abstract provides limited procedural detail and outcomes
Future Directions: Define safe oxygen/flow thresholds and monitoring protocols for neonatal respiratory support; develop checklists to minimize iatrogenic barotrauma.
This case report discusses the neonatal management of a term baby born with normal parameters but developed respiratory distress shortly after birth. Initially, the baby presented with blue extremities, respiratory distress and grunting. He was placed on a nasal cannula, 6 L, 25% FiO